Literature DB >> 11836275

Long-term follow-up of functional hypothalamic amenorrhea and prognostic factors.

Leopoldo Falsetti1, Alessandro Gambera, Lorena Barbetti, Cristina Specchia.   

Abstract

This study evaluated the prognosis of functional hypothalamic amenorrhea (FHA) and the predictive factors of recovery, through a long-term follow-up. Ninety-three women affected by FHA underwent a follow-up for an average period of 8.1 yr (range 7-9 yr). At the end of the follow-up, 65 (70.7%) patients recovered. Statistical analysis showed that there was no association between recovery and anamnestic causes of FHA or with the echographic ovarian morphology but identified the predictive factors of recovery as the basal body mass index (BMI), the basal cortisol, and androstenedione plasma levels. A higher basal BMI and A, and lower cortisol values are positive prognostic factors for the recovery. Also the BMI, acquired during the follow-up, is important for FHA resolution: in fact, in recovered women the BMI increased or remained stable, whereas in nonrecovered women it decreased or remained stable. At the end of the follow-up, 52 (74.3%) patients treated with hormone replacement therapy and 8 (80%) with no therapy recovered, but only 5 (41.7%) with oral contraceptive pills recovered.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836275     DOI: 10.1210/jcem.87.2.8195

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  Food Versus Pharmacy: Assessment of Nutritional and Pharmacological Strategies to Improve Bone Health in Energy-Deficient Exercising Women.

Authors:  Emily A Southmayd; Adelaide C Hellmers; Mary Jane De Souza
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

Review 2.  Prolactin, psychological stress and environment in humans: adaptation and maladaptation.

Authors:  Luis Gonçalves Sobrinho
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

3.  Resumption of menstruation and pituitary response to gonadotropin-releasing hormone in functional hypothalamic amenorrhea subjects undertaking estrogen replacement therapy.

Authors:  Z Q Shen; J J Xu; J F Lin
Journal:  J Endocrinol Invest       Date:  2013-04-18       Impact factor: 4.256

4.  Premenopausal osteoporosis: Focus on the female athlete triad.

Authors:  Guido Zavatta; Bart L Clarke
Journal:  Case Rep Womens Health       Date:  2020-11-27

5.  The Impact of the COVID-19 Pandemic on Women's Reproductive Health.

Authors:  Niamh Phelan; Lucy Ann Behan; Lisa Owens
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-22       Impact factor: 5.555

Review 6.  Functional hypothalamic amenorrhea: Impact on bone and neuropsychiatric outcomes.

Authors:  Clarissa Carvalho Pedreira; Jacqueline Maya; Madhusmita Misra
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

Review 7.  Current understanding of hypothalamic amenorrhoea.

Authors:  Rachel E Roberts; Linda Farahani; Lisa Webber; Channa Jayasena
Journal:  Ther Adv Endocrinol Metab       Date:  2020-07-30       Impact factor: 3.565

8.  Increased Burden of Rare Sequence Variants in GnRH-Associated Genes in Women With Hypothalamic Amenorrhea.

Authors:  Angela Delaney; Adam B Burkholder; Christopher A Lavender; Lacey Plummer; Veronica Mericq; Paulina M Merino; Richard Quinton; Katie L Lewis; Brooke N Meader; Alessandro Albano; Natalie D Shaw; Corrine K Welt; Kathryn A Martin; Stephanie B Seminara; Leslie G Biesecker; Joan E Bailey-Wilson; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 6.134

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.